1. +
Rowland,
LP: Diverse forms of motor neuron diseases. Adv Neurol 36:1, 1982.
2. +
Swash,
M: Clinical features and diagnosis of amyotrophic lateral sclerosis. In Brown,
R, Jr, Meininger,
V, and Swash,
M (eds): Amyotrophic Lateral Sclerosis. Martin Dunitz Ltd, London, 2000, p 3.
3. +
Norris,
F,
et al: Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 118(1):48, 1993.
[PubMed: 8229050]
4. +
Pradas,
J,
et al: The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials. Neurology 43(4):751, 1993.
[PubMed: 8469335]
5. +
Ringel,
SP,
et al: The natural history of amyotrophic lateral sclerosis. Neurology 43(7):1316, 1993.
[PubMed: 8327132]
6. +
Haverkamp,
LJ, Appel,
V, and Appel,
SH: Natural history of amyotrophic lateral sclerosis in a database population: Validation of a scoring system and a model for survival prediction. Brain 118:707, 1995.
[PubMed: 7600088]
7. +
Gubbay,
SS,
et al: Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 232(5):295, 1985.
[PubMed: 4056836]
8. +
Appel,
SH,
et al: Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol 43(3):234, 1986.
[PubMed: 3484947]
9. +
Mulder,
DW,
et al: Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36(4):511, 1986.
[PubMed: 3960325]
10. +
Strong,
MJ, Hudson,
AJ, and Alvord,
WG: Familial amyotrophic lateral sclerosis, 1850–1989: A statistical analysis of the world literature. Can J Neurol Sci 18:45, 1991.
[PubMed: 2036615]
11. +
Hamida,
MB, and Hentati,
F: Juvenile amyotrophic lateral sclerosis. In Brown,
R, Jr, Meininger,
V, and Swash,
M (eds): Amyotrophic Lateral Sclerosis. Martin Dunitz Ltd, London, 2000, p 59.
12. +
Rosen,
DR: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59, 1993.
[PubMed: 8446170]
13. +
Jackson,
M, and Rothstein,
JD: Amyotrophic lateral sclerosis. In Marcoux,
FW, and Choi,
DW (eds): Central Nervous System Neuroprotection. Springer, New York, 2002, p 423.
14. +
Jackson,
M,
et al: Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: Homozygous NAIP deletion in a sporadic case. Ann Neurol 39(6):796, 1996.
[PubMed: 8651652]
15. +
Robberecht,
W,
et al: D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 47(5):1336, 1996.
[PubMed: 8909456]
16. +
Caroscio,
JT, Calhoun,
WF, and Yahr,
MD: Prognostic factors in motor neuron disease: A prospective study of longevity. In Rose,
FC (ed): Research Progress in Motor Neuron Disease. Pitman, London, 1984, p 34.
17. +
Brooks,
BR: The natural history of amyotrophic lateral sclerosis. In Williams,
AC (ed): Motor Neurone Disease. Chapman & Hall, London, 1994, p 121.
18. +
Hosler,
BA, and Brown,
RH, Jr: Copper/zinc superoxide dismutase mutations and free radical damage in amyotrophic lateral sclerosis. Adv Neurol 68:41, 1995.
[PubMed: 8787241]
19. +
Rothstein,
JD,
et al: Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 91(10):4155, 1994.
[PubMed: 7910402]
20. +
Borchelt,
DR,
et al: Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91(17):8292, 1994.
[PubMed: 8058797]
21. +
Plaitakis,
A, and Caroscio,
JT: Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 22(5):575, 1987.
[PubMed: 2892463]
22. +
Rothstein,
JD,
et al: Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28(1):18, 1990.
[PubMed: 2375630]
23. +
Rothstein,
JD, Martin,
LJ, and Kuncl,
RW: Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326(22):1464, 1992.
[PubMed: 1349424]
24. +
Rothstein,
JD,
et al: Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38(1):73, 1995.
[PubMed: 7611729]
25. +
Carpenter,
S: Proximal axonal enlargement in motor neuron disease. Neurology 18:841, 1968.
[PubMed: 4176657]
26. +
Hirano,
A,
et al: Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 43(5):471, 1984.
[PubMed: 6540800]
27. +
Wolfgang,
F, and Myers,
L: Amyotrophic lateral sclerosis: Effect of serum on anterior horn cells in tissue culture. Science 179:579, 1973.
[PubMed: 4119685]
28. +
Troost,
D, Van den Oord,
JJ, and Vianney de Jong,
JM: Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 16(5):401, 1990.
[PubMed: 2263315]
29. +
Smith,
RG,
et al: Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 24(327):1721, 1992.
30. +
Appel,
SH: A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol 10(6):499, 1981.
[PubMed: 6173010]
31. +
Lindsay,
RM: Brain-derived neurotrophic factor: an NGF-related neurotrophin. In Loughlin,
SE, and Fallon,
JH (eds): Neurotrophic Factors. Academic Press, San Diego, 1993, p 257.
32. +
Thoenen,
H, Hughes,
RA, and Sendtner,
M: Trophic support of motoneurons: Physiological, pathophysiological, and therapeutic implications. Exp Neurol 124(1):47, 1993.
[PubMed: 8282079]
33. +
Anand,
P,
et al: Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease. Nat Med 1(2):168, 1995.
[PubMed: 7585015]
34. +
Strong,
MJ: Exogenous neurotoxins. In Brown,
R, Jr, Meininger,
V, and Swash,
M (eds): Amyotrophic Lateral Sclerosis. Martin Dunitz Ltd, London, 2000, p 279.
35. +
Brown,
R, Jr: Apoptosis in amyotrophic lateral sclerosis: A review. In Brown,
R, Jr, Meininger,
V, and Swash,
M (eds): Amyotrophic Lateral Sclerosis. Martin Dunitz Ltd, London, 2000, p 363.
36. +
Mitsumoto,
H, Chad,
DA, and Pioro,
EK: Hypotheses for viral and other transmissable agents in amyotrophic lateral sclerosis. In Mitsumoto,
H, Chad,
DA, and Pioro,
EK (eds): Amyotrophic Lateral Sclerosis. FA Davis, Philadelphia, 1998, p 239.
37. +
Mizutani,
T,
et al: Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol 84(4):372, 1992.
[PubMed: 1441918]
38. +
Iwata,
M, and Hirano,
A: Sparing of the Onufrowicz nucleus in sacral anterior horn lesions. Ann Neurol 4(3):245, 1978.
[PubMed: 718135]
39. +
Mannen,
T, and
et al: Preservation of certain motorneurone group of the sacral cord in amyotrophic lateral sclerosis: Its clinical significance. J Neuropathol Exp Neurol 47:642, 1988.
[PubMed: 2459315]
40. +
Barr,
ML, and Kiernan,
JA: The Human Nervous System: An Anatomical Viewpoint, ed 6. JB Lippincott, Philadelphia, 1993.
41. +
Bradley,
WG,
et al: Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol 14(3):267, 1983.
[PubMed: 6195954]
42. +
Heads,
T,
et al: Sensory nerve pathology in amyotrophic lateral sclerosis. Acta Neuropathol 82(4):316, 1991.
[PubMed: 1662002]
43. +
Kawamura,
Y,
et al: Morphometric comparison in the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 40(6):667, 1988.
44. +
Swash,
M,
et al: Selective and asymmetric vulnerability of corticospinal and spinocerebellar tracts in motor neuron disease. J Neurol Neurosurg Psychiatry 51(6):785, 1988.
[PubMed: 3165441]
45. +
Averback,
P, and Crocker,
P: Regular involvement of Clarke's nucleus in sporadic amyotrophic lateral sclerosis. Arch Neurol 39(3):155, 1982.
[PubMed: 7065933]
46. +
Takahaski,
H,
et al: Clarke's column in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 84(5):465, 1992.
[PubMed: 1462760]
47. +
Hudson,
AJ: Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: A review. Brain 104(2):217, 1981.
[PubMed: 7016254]
48. +
Wohlfart,
G: Collateral regeneration in partially denervated muscles. Neurology 8(3):175, 1958.
[PubMed: 13517482]
49. +
Hansen,
S, and Ballantyne,
JP: A quantitative electrophysiological study of motor neurone disease. J Neurol Neurosurg Psychiatry 41(9):773, 1978.
[PubMed: 690647]
50. +
McComas,
AJ,
et al: Functional compensation in partially denervated muscles. J Neurol Neurosurg Psychiatry 34(4):453, 1971.
[PubMed: 4938133]
51. +
Swash,
M, and Schwartz,
MS: A longitudinal study of changes in motor units in motor neuron disease. J Neurol Sci 56(2–3): 185, 1982.
[PubMed: 6294255]
52. +
Swash,
M, and Schwartz,
MS: Staging motor neurone disease: Single fibre EMG studies of asymmetry, progression and compensatory reinnervation. In Rose,
FC (ed): Research Progress in Motor Neuron Disease. Pitman, London, 1984, p 123.
53. +
Brooks,
BR,
et al: Natural history of amyotrophic lateral sclerosis: Quantification of symptoms, signs, strength and function. In Serratrice,
G, and Munsat,
TL (eds): Advances in Neurology: Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis. Lippincott-Raven, Philadelphia, 1995, p 163.
54. +
Mitsumoto,
H, Chad,
DA, and Pioro,
EK: Clinical features: Signs and symptoms. In Mitsumoto,
H, Chad,
DA, and Pioro,
EK (eds): Amyotrophic Lateral Sclerosis. FA Davis, Philadelphia, 1998, p 47.
55. +
Brooks,
BR: Natural history of ALS: Symptoms, strength, pulmonary function, and disability. Neurology 47(Suppl): S71, 1996.
[PubMed: 8858055]
56. +
Jette,
DU,
et al: The relationship of lower-limb muscle force to walking ability in patients with amyotrophic lateral sclerosis. Phys Ther 79(7):672, 1999.
[PubMed: 10416576]
57. +
Dal Bello-Haas,
V,
et al: Development, analysis, refinement, and utility of an interdisciplinary amyotrophic lateral sclerosis database. Amyotroph Lateral Scler Other Motor Neuron Disord 2(1):39, 2001.
[PubMed: 11465932]
58. +
Kilmer,
DD: The role of exercise in neuromuscular disease. Phys Med Rehabil Clin North Am 9(1):115, 1998.
59. +
Sanjak,
M,
et al: Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology 37(7):1217, 1987.
[PubMed: 3601086]
60. +
Sharma,
KR,
et al: Physiology of fatigue in amyotrophic lateral sclerosis. Neurology 45(4):733, 1995.
[PubMed: 7723963]
61. +
Sahrmann,
SA, and Norton,
BJ: The relationship of voluntary movement to spasticity in the upper motor neuron syndrome. Ann Neurol 2(6):460, 1977.
[PubMed: 617588]
62. +
Mayer,
NH: Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl 6:S1, 1997.
[PubMed: 9826979]
63. +
Schiffer,
RB, Cash,
J, and Herndon,
RM: Treatment of emotional lability with low-dosage tricyclic antidepressants. Psychosomatics 24(12):1094, 1983.
[PubMed: 6665116]
64. +
Gallagher,
JP: Pathologic laughter and crying in ALS: A search for their origin. Acta Neurol Scand 80(2):114, 1989.
[PubMed: 2816272]
65. +
Fallat,
RJ,
et al: Spirometry in amyotrophic lateral sclerosis. Arch Neurol 36(2):74, 1979.
[PubMed: 420626]
66. +
Rochester,
DF, and Esau,
SA: Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 15(4):751, 1994.
[PubMed: 7867289]
67. +
Vitacca,
M,
et al: Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. Eur Respir J 10(7):1614, 1997.
[PubMed: 9230256]
68. +
Krivickas,
L: Pulmonary function and respiratory failure. In Mitsumoto,
H, Chad,
DA, and Pioro,
EK (eds): Amyotrophic Lateral Sclerosis. FA Davis, Philadelphia, 1998, p 382.
69. +
Schiffman,
PL, and Belsh,
JM: Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest 103(2):508, 1993.
[PubMed: 8432145]
70. +
Abe,
K,
et al: Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci 148(1):95, 1997.
[PubMed: 9125395]
71. +
Kew,
JJM,
et al: The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain 116:1399, 1993.
[PubMed: 8293278]
72. +
Wilson,
CM,
et al: Cognitive impairment in sporadic ALS: A pathologic continuum underlying a multisystem disorder. Neurology 57(4):651, 2001.
[PubMed: 11524474]
73. +
Massman,
PJ,
et al: Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 61(5):450, 1996.
[PubMed: 8937336]
74. +
Lomen-Hoerth,
C,
et al: Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60(7):1094, 2003.
[PubMed: 12682312]
75. +
Neary,
D,
et al: Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 53(1):23, 1990.
[PubMed: 2303828]
76. +
Strong,
MJ,
et al: A prospective study of cognitive impairment in ALS. Neurology 53(8):1665, 1999.
[PubMed: 10563610]
77. +
Abrahams,
S,
et al: Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 38(6):734, 2000.
[PubMed: 10689049]
78. +
Abrahams,
S,
et al: Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 62(5):464, 1997.
[PubMed: 9153602]
79. +
Brooks,
BR,
et al: El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293, 2000.
[PubMed: 11464847]
80. +
Juergens,
SM,
et al: ALS in Rochester, Minnesota. Neurology 30(5):463, 1980.
[PubMed: 7189252]
81. +
Caroscio,
JT,
et al: Amyotrophic lateral sclerosis: Its natural history. Neurol Clin 5(1):1, 1987.
82. +
Kristensen,
O, and Melgaard,
B: Motor neuron disease: Prognosis and epidemiology. Acta Neurol Scand 56(4):299, 1977.
[PubMed: 920110]
83. +
Granieri,
E,
et al: Motor neuron disease in the province of Ferrara, Italy, in 1964–1982. Neurology 38(10):1604, 1988.
[PubMed: 3419606]
84. +
Tysnes,
OB, Vollset,
SE, and Aarli,
JA: Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand 83(5):280, 1991.
[PubMed: 2063649]
85. +
Rosen,
AD: Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 35(10):638, 1978.
[PubMed: 697604]
86. +
Tysnes,
OB,
et al: Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology 13(5):226, 1994.
[PubMed: 7969707]
87. +
McDonald,
ER,
et al: Survival in amyotrophic lateral sclerosis: The role of psychological factors. Arch Neurol 51(1):17, 1994.
[PubMed: 8274106]
88. +
Johnston,
M,
et al: Mood as a predictor of disability and survival in patients diagnosed with ALS/MND. Br J Health Psych 4(2):1999, 1999.
89. +
Traynor,
BJ,
et al: Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: A population based study, 1996–2000. J Neurol Neurosurg Psychiatry 74(9):1258, 2003.
[PubMed: 12933930]
90. +
Bensimon,
G, Lacomblez,
L, and Meininger,
V: A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330(9):585, 1994.
[PubMed: 8302340]
91. +
Lacomblez,
L,
et al: Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347(9013):1425, 1996.
93. +
Gordon,
PH: Amyotrophic lateral sclerosis: Pathophysiology, diagnosis and management. CNS Drugs 25(1):1, 2011.
94. +
Miller,
RG,
et al: Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1218, 2009.
[PubMed: 19822872]
95. +
Miller,
RG,
et al: Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1227, 2009.
[PubMed: 19822873]
96. +
Desport,
JC,
et al: Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53(5):1059, 1999.
[PubMed: 10496266]
97. +
Lechtzin,
N,
et al: Hospitalization in amyotrophic lateral sclerosis: Causes, costs, and outcomes. Neurology 56(6):753, 2001.
[PubMed: 11274310]
98. +
Hillel,
AD, and Miller,
R: Bulbar amyotrophic lateral sclerosis: Patterns of progression and clinical management. Head Neck 11(1):51, 1989.
[PubMed: 2921111]
99. +
Miller,
RG,
et al (ALS Practice Parameters Task Force): The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 52(7):1311, 1999.
[PubMed: 10227612]
100. +
Mathus-Vliegen,
LMH,
et al: Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc 40(4):463, 1994.
[PubMed: 7926537]
101. +
Mazzini,
L,
et al: Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. Neurology 242(10):695, 1995.
102. +
Jarnagin,
WR,
et al: The efficacy and limitations of percutaneous endoscopic gastrostomy. Arch Surg 127(3):261, 1992.
[PubMed: 1550470]
103. +
Kadakia,
SC, Sullivan,
HO, and Starnes,
E: Percutaneous endoscopic gastrostomy or jejunostomy and the incidence of aspiration in 79 patients. Am J Surg 164(2):114, 1992.
[PubMed: 1636889]
104. +
Piper,
AJ, and Sullivan,
CE: Effects of long-term nocturnal nasal ventilation on spontaneous breathing during sleep in neuromuscular and chest wall disorders. Eur Respir J 9(7):1515, 1996.
[PubMed: 8836668]
105. +
Cazzolli,
PA, and Oppenheimer,
EA: Home mechanical ventilation for amyotrophic lateral sclerosis: Nasal compared to tracheostomy-intermittent positive pressure ventilation. J Neurol Sci 139(Suppl): 123, 1996.
106. +
Pinto,
AC,
et al: Respiratory assistance with a non-invasive ventilator (BiPAP) in MND/ALS patients: Survival rates in a controlled trial. J Neurol Sci 129(Suppl):19, 1995.
[PubMed: 7595610]
107. +
Aboussouan,
LS,
et al: Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 127(6):450, 1997.
[PubMed: 9313002]
108. +
Bach,
JR: Respiratory muscle aids for the prevention of pulmonary morbidity and mortality. Semin Neurol 15(1):72, 1995.
[PubMed: 7638462]
109. +
Yorkston,
KM,
et al: Speech deterioration in amyotrophic lateral sclerosis: Implications for the timing of intervention. J Med Speech-Language Pathol 1:35, 1993.
110. +
Adams,
L, and Kazandijan,
M: Managing communication and swallowing difficulties. In Mitsumoto,
M, and Munsat,
T (eds): Amyotrophic Lateral Sclerosis: A Guide for Patients and Families. Demos Medical Publishing, New York, 2001, p 133.
111. +
Esposito,
SJ, Mitsumoto,
H, and Shanks,
M: Use of palatal lift and palatal augmentation prostheses to improve dysarthria in patients with amyotrophic lateral sclerosis: A case series. J Prosthet Dent 83(1):90, 2000.
[PubMed: 10633027]
112. +
Gelinas,
DF, and Miller,
RG: A treatable disease: A guide to management of amyotrophic lateral sclerosis. In Brown,
R, Jr, Meininger,
V, and Swash,
M (eds): Amyotrophic Lateral Sclerosis. Martin Dunitz Ltd, London, 2000, p 405.
113. +
Dal Bello-Haas,
V: A framework for rehabilitation in degenerative diseases: Planning care and maximizing quality of life. Neurology Report (now JNPT) 26(3):115, 2002.
114. +
Folstein,
M, Folstein,
SE, and McHugh,
PR: Mini Mental State: A practical guide for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189, 1975.
[PubMed: 1202204]
115. +
Beck,
AT,
et al: An inventory for measuring depression. Arch Gen Psychiatry 4:561, 1961.
[PubMed: 13688369]
116. +
Radloff,
LS: CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385, 1977.
117. +
Zigmond,
AS, and Snaith,
RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361, 1983.
[PubMed: 6880820]
118. +
Spielberger,
CS, Gorsuch,
RL, and Lushene,
RE: Manual for the State Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA, 1970.
119. +
Andres,
PL,
et al: Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 36(7):937, 1986.
[PubMed: 3714055]
120. +
deBoer,
A, Boukes,
RJ, and Sterk,
JC: Reliability of dynamometry in patients with neuromuscular disorders. N Engl J Med 11(11):169, 1982.
121. +
Scott,
OM,
et al: Quantification of muscle function in children: A prospective study in Duchenne muscular dystrophy. Muscle Nerve 5(4):291, 1982.
[PubMed: 7099196]
122. +
Munsat,
TL, Andres,
P, and Skerry,
L: Therapeutic trials in amyotrophic lateral sclerosis: Measurement of clinical deficit. In Rose,
C (ed): Amyotrophic Lateral Sclerosis. Demos, New York, 1990, p 65.
123. +
Brooks,
BR,
et al: Design of clinical therapeutic trials in amyotrophic lateral sclerosis. Adv Neurol 56:521, 1991.
[PubMed: 1853781]
124. +
Great Lakes ALS Study Group: A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis. Neurology 61(11):1503, 2003.
[PubMed: 14663032]
125. +
Bohannon,
RW, and Smith,
MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67(2):206, 1987.
[PubMed: 3809245]
126. +
Tinetti,
ME: Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 34(2):119, 1986.
[PubMed: 3944402]
127. +
Berg,
KO,
et al: Measuring balance in the elderly: Validation of an instrument. Can J Public Health 83(2 Suppl):S7, 1992.
[PubMed: 1468055]
128. +
Podsiadlo,
D, and Richardson,
S: The timed "Up and Go": A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142, 1991.
[PubMed: 1991946]
129. +
Duncan,
PW,
et al: Functional reach: A new clinical measure of balance. J Gerontol 45(6):M192, 1990.
[PubMed: 2229941]
130. +
Kloos,
A,
et al: Interrater and intrarater reliability of the Tinetti Balance Test for individuals with amyotrophic lateral sclerosis. JNPT 28(1):12, 2004.
131. +
Kloos,
A,
et al: Validity of the Tinetti Balance Assessment in individuals with amyotrophic lateral sclerosis. Proceedings of the 9th International Symposium on ALS/MND, Munich, Germany.
132. +
Montes,
J,
et al: The Timed Up and Go test: Predicting falls in ALS. Amyotroph Lateral Scler 8(5):292, 2007.
133. +
Guide for the Uniform Data Set for Medical Rehabilitation (including the FIM instrument), Version 5.0. State University of New York, Buffalo, 1996.
134. +
Schwab,
R, and England,
A: Projection technique for evaluating surgery in Parkinson's disease. In Gillingham,
J, and Donaldson,
I (eds): Third Symposium on Parkinson's Disease. Livingstone, Edinburgh, Scotland, 1969.
135. +
The ALS CNTF Treatment Study (ACTS) Phase I–II Study Group: The amyotrophic sclerosis functional rating scale: Assessment of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53:141, 1996.
[PubMed: 8639063]
136. +
Krupp,
LB,
et al: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121, 1989.
[PubMed: 2803071]
137. +
Cedarbaum,
JM,
et al: The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13, 1999.
[PubMed: 10540002]
138. +
Kaufmann,
P,
et al: Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. Amyotroph Lateral Scler 8(1):42, 2007.
[PubMed: 17364435]
139. +
Appel,
V,
et al: A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience. Ann Neurol 22(3):328, 1987.
[PubMed: 3118763]
140. +
Hillel,
AD,
et al: Amyotrophic Lateral Sclerosis Severity Scale. Neuroepidemiology 8(3):142, 1989.
[PubMed: 2725806]
141. +
Norris,
F,
et al: The administration of guanidine in amyotrophic lateral sclerosis. Neurology 24(8):721, 1974.
[PubMed: 4858705]
142. +
Ware,
JE,
et al: SF-36 Health Survey: Manual and Interpretation Guide. Health Institute, New England Medical Center, Boston, 1993.
143. +
Hickey,
AM,
et al: A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS. Br Med J 313(7048):29, 1996.
144. +
Bergner,
M,
et al: The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 19(8):787, 1981.
[PubMed: 7278416]
145. +
Jenkinson,
C,
et al: Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neuron disease: The ALSAQ-40. J Neurol 246:16, 1999.
[PubMed: 9987709]
146. +
Jenkinson,
C,
et al: Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotroph Lateral Scler Other Motor Neuron Disord 1(1):33, 1999.
[PubMed: 12365067]
147. +
Jenkinson,
C, and Fitzpatrick,
R: Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: Development and validation of the ALSAQ-5. J Neurol Neurosurg Psychiatry 70(1):70, 2001.
[PubMed: 11118250]
148. +
Dal Bello-Haas,
V,
et al: A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 68(23):2003, 2007.
[PubMed: 17548549]
149. +
Ingels,
PL,
et al: Adhesive capsulitis: A common occurrence in patients with ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2(S2):60, 2001.
150. +
Cheah,
BC,
et al: INSPIRATIonAL—INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10(5-6):384, 2009.
[PubMed: 19922129]
151. +
Lahrmann,
H,
et al: Expiratory muscle weakness and assisted cough in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 4(1):49, 2003.
[PubMed: 12745619]
152. +
Hanayama,
K, Ishikawa,
Y, and Bach,
JR: Amyotrophic lateral sclerosis: Successful treatment of mucous plugging by mechanical insufflation-exsufflation. Am J Phys Med Rehabil 76(4):338, 1997.
[PubMed: 9267195]
153. +
Mustfa,
N,
et al: Cough augmentation in amyotrophic lateral sclerosis. Neurology 61(9):1285, 2003.
[PubMed: 14610141]
154. +
Scherer,
TA,
et al: Effect of high-frequency oral airway and chest wall oscillation and conventional chest physical therapy on expectoration in patients with stable cystic fibrosis. Chest 113(4):1019, 1998.
[PubMed: 9554641]
155. +
Arens,
R,
et al: Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med 150(4):1154, 1994.
[PubMed: 7921452]
156. +
Lange,
DJ,
et al: High-frequency chest wall oscillation in ALS: An exploratory randomized, controlled trial. Neurology 67(6):991, 2006.
[PubMed: 17000967]
157. +
Trail,
M,
et al: Wheelchair use by patients with amyotrophic lateral sclerosis: A survey of user characteristics and selection preferences. Arch Phys Med Rehabil 82(1):98, 2001.
[PubMed: 11239293]
158. +
Ashworth,
NL, Satkunam,
LE, and Deforge,
D: Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease (Cochrane review). The Cochrane Library, Issue 4. Jon Wiley & Sons, Chichester, UK, 2004.
159. +
Kemp,
C: Psychosocial needs, problems, and interventions: The individual. In Terminal Illness: A Guide to Nursing Care. Lippincott, Philadelphia, 1999, p 17.
160. +
Doka,
KJ: Mourning psychosocial loss: Anticipatory mourning in Alzheimer's, ALS, and irreversible coma. In Rando,
TA (ed): Clinical Dimensions of Anticipatory Mourning: Theory and Practice in Working with the Dying, Their Loved Ones, and Their Caregivers. Research Press, Champaign, IL, 2000, p 477.
161. +
Dal Bello-Haas,
V, Delbene,
M, and Mitsumoto,
H: End of life: Challenges and strategies for the rehabilitation professional. Neurological Report (now JNPT) 26(4):174, 2002.
162. +
Kilmer,
DD,
et al: The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 75(5):560, 1994.
[PubMed: 8185450]
163. +
Lindeman,
E,
et al: Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: A randomized clinical trial. Arch Phys Med Rehabil 76(7):612, 1995.
[PubMed: 7605179]
164. +
Aitkens,
SG,
et al: Moderate resistance exercise program: Its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 74(7):711, 1993.
[PubMed: 8328892]
165. +
Milner-Brown,
HS, and Miller,
RG: Muscle strengthening through high-resistance weight training in patients with neuromuscular disorders. Arch Phys Med Rehabil 69(1):14, 1988.
[PubMed: 3337636]
166. +
Florence,
JM, and Hagberg,
JM: Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc 16(5):460, 1984.
[PubMed: 6513764]
167. +
Vignos,
PJJ: Physical models of rehabilitation in neuromuscular disease. Muscle Nerve 6(5):323, 1983.
[PubMed: 6888414]
168. +
Einarsson,
G: Muscle conditioning in late poliomyelitis. Arch Phys Med Rehabil 72(1):11, 1991.
[PubMed: 1985616]
169. +
McCartney,
N,
et al: The effects of strength training in patients with selected neuromuscular disorders. Med Sci Sports Exerc 20(4):362, 1988.
[PubMed: 3173043]
170. +
Bennett,
RL, and Knowlton,
GC: Overwork weakness in partially denervated skeletal muscle. Clin Orthop 12:22, 1958.
[PubMed: 13619074]
171. +
Johnson,
EW, and Braddom,
R: Over-work weakness in facioscapulohumeral muscular dystrophy. Arch Phys Med Rehabil 52(7):333, 1971.
[PubMed: 5565885]
172. +
Tam,
SL,
et al: Increased neuromuscular activity reduces sprouting in partially denervated muscles. J Neurosci 21(2):654, 2001.
[PubMed: 11160444]
173. +
Gardiner,
PF, Michel,
R, and Iadeluca,
G: Previous exercise training influences functional sprouting of rat hind limb motoneurons in response to partial denervation. Neurosci Lett 45(2):123, 1984.
[PubMed: 6328371]
174. +
Rafuse,
VF, Gordon,
T, and Orozco,
R: Proportional enlargement of motor units after partial denervation of cat triceps surae muscles. J Neurophysiol 68(4):1261, 1992.
[PubMed: 1432083]
175. +
Michel,
RN, and Gardiner,
PF: Influence of overload on recovery of rat plantaris from partial denervation. J Appl Physiol 66(2): 732, 1989.
[PubMed: 2708202]
176. +
Seburn,
KL, and Gardiner,
PF: Properties of sprouted rat motor units: Effects of period of enlargement and activity level. Muscle Nerve 19(9):1100, 1996.
[PubMed: 8761265]
177. +
Ribchester,
RR: Activity-dependent and independent synaptic interactions during reinnervation of partially denervated rat muscle. J Physiol (Lond) 401:53, 1988.
[PubMed: 3171995]
178. +
Einsiedel,
LJ, and Luff,
AR: Activity and motor unit size in partially denervated rat medial gastrocnemius. J Appl Physiol 76(6):2663, 1994.
[PubMed: 7928898]
179. +
Coble,
NO, and Maloney,
FP: Effects of exercise in neuromuscular disease. In Maloney,
FP, Burks,
JS, and Ringel,
SP (eds): Interdisciplinary Rehabilitation of Multiple Sclerosis and neuromuscular Disorders. Lippincott, New York, 1985, p 228.
180. +
Bohanon,
RW: Results of resistance exercise on a patient with amyotrophic lateral sclerosis. Phys Ther 63(6):965, 1983.
[PubMed: 6856684]
181. +
Sanjak,
M, Reddan,
W, and Brooks,
BR: Role of muscular exercise in amyotrophic lateral sclerosis. Neurol Clin 5(2):251, 1987.
[PubMed: 11681402]
182. +
Pinto,
AC,
et al: Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci 169:69, 1999.
[PubMed: 10540010]
183. +
Drory,
VE,
et al: The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 191(1-2):133, 2001.
[PubMed: 11677004]
184. +
Kirkinezos,
IG,
et al: Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 53(6):804, 2003.
[PubMed: 12783429]
185. +
Veldink,
JH,
et al: Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromusc Disord 13(9):737, 2003.
[PubMed: 14561497]
186. +
Mahoney,
DJ,
et al: Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 29(5):656, 2004.
[PubMed: 15116368]
187. +
Liebetanz,
D,
et al: Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 20(11):3115, 2004.
[PubMed: 15579165]
188. +
Deforges,
S,
et al: Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol (Lond) 587(14):3561, 2009.
[PubMed: 19491245]
189. +
Carreras,
I,
et al: Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res 1313: 192, 2010.
[PubMed: 19968977]